How to treat small intestine neuroendocrine tumor

Treatment of neuroendocrine tumors of the small intestine includes surgery, drugs,(somatostatin analog, targeted therapy, etc.), radiotherapy, interventional therapy, etc. The specific scheme should be comprehensively considered according to factors such as tumor condition and patient's physical condition, and regular follow-up should be conducted after treatment. The treatment of neuroendocrine tumors of the small intestine mainly includes surgical treatment and drug treatment (including somatostatin analogs, targeted therapies, etc.) and other therapeutic approaches (Such as radiotherapy, interventional therapy, etc.), the specific treatment plan should be based on the tumor size, location, grade, patient's age and health status and other factors comprehensively considered. Surgical treatment is the main treatment method for small intestinal neuroendocrine tumors. For localized tumors, surgical resection can achieve curative effect. For metastatic tumors, surgical treatment can alleviate symptoms and prolong the survival period of patients. Drug therapy is mainly used for patients who cannot be operated or relapse and metastasis after surgery. Somatostatin analogues can inhibit tumor growth and secretion, alleviate symptoms and prolong survival of patients. Targeted therapy is targeted at specific targets of tumor cells, which can inhibit tumor cell growth and spread. In addition, radiotherapy and interventional therapy can also be used for the treatment of small intestinal neuroendocrine tumors. Radiotherapy can kill tumor cells, interventional therapy can treat tumors through vascular embolization, chemotherapy, etc. For patients with small intestinal neuroendocrine tumors, follow-up after treatment is very important, including regular imaging examinations and tumor marker detection to monitor tumor recurrence and metastasis. It should be noted that the treatment of small intestinal neuroendocrine tumors requires the collaboration of multidisciplinary teams, including surgeons, physicians, radiologists, etc., to develop personalized treatment plans according to the specific conditions of patients. At the same time, patients also need to actively cooperate with treatment to maintain a good attitude and improve quality of life. In conclusion, the treatment of small intestinal neuroendocrine tumors requires comprehensive consideration of multiple factors, individualized treatment protocols, and active cooperation and follow-up of patients.